C
Cognition Therapeutics, Inc. (CGTX)
NCM – Real vaqt narxi. Valyuta: USD
0.73
-0.35 (-32.40%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.74
+0.01 (2.00%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
0.73
-0.35 (-32.40%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.74
+0.01 (2.00%)
Bozordan keyin: Mar 27, 2026, 7:59 PM EDT
Cognition Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, yoshga bog'liq degenerativ kasalliklar va markaziy asab tizimi hamda retinaning buzilishlarini maqsad qilgan kichik molekulali terapevtik vositalarni kashf qilish va ishlab chiqish bilan shug'ullanadi. Uning asosiy mahsulot nomzodi CT1812, og'iz orqali yuboriladigan molekulalar modulyatori bo'lib, u qon-miya to'sig'ini o'tkazish va S2R kompleksiga selektiv ravishda bog'lanish uchun ishlab chiqilgan, bu esa Altsgeymer kasalligini, shuningdek, quruq yoshga bog'liq makula degeneratsiyasidan kelib chiqqan geografik atrofiya va Lewi jismlari bilan demensiya kabi sinukleinopatiyalarni davolash bo'yicha 2-bosqich klinik sinovlarida. Cognition Therapeutics, Inc. 2007 yilda tashkil etilgan va Purchase, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Anthony O. Caggiano M.D., Ph.D. | Chief Medical Officer |
| Dr. Steven A. Weissman Ph.D. | VP & Head of CMC |
| Mr. Bobby Horn | Corporate Controller |
| Mr. John Brendan Doyle | Chief Financial Officer |
| Ms. Anita Cornet | Head of Quality |
| Ms. Lisa Ricciardi | CEO, President & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-02 | 8-K | tm267638d1_8k.htm |
| 2026-01-27 | 8-K | tm264096d1_8k.htm |
| 2025-12-18 | 8-K | tm2533712d1_8k.htm |
| 2025-11-06 | 10-Q | cgtx-20250930x10q.htm |
| 2025-09-15 | 8-K | tm2525997d1_8k.htm |
| 2025-08-28 | 8-K | tm2524576d2_8k.htm |
| 2025-08-26 | 8-K | tm2524388d1_8k.htm |
| 2025-08-07 | 8-K | tm2522152d2_8k.htm |
| 2025-06-20 | 8-K | tm2518439d2_8k.htm |
| 2025-06-03 | 8-K | tm2516905d1_8k.htm |